Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
A collection of Aspergillus fumigatus mutants highly resistant to itraconazole (RIT) at 100 μg ml −1 were selected in vitro (following UV irradiation as a preliminary step) to investigate mechanisms of drug resistance in this clinically important pathogen. Eight of the RIT mutants were found to have a mutation at Gly54 (G54E, -K, or -R) in the azole target gene CYP51A . Primers designed for highly conserved regions of multidrug resistance (MDR) pumps were used in reverse transcriptase PCR amplification reactions to identify novel genes encoding potential MDR efflux pumps in A. fumigatus . Two genes, AfuMDR3 and AfuMDR4 , showed prominent changes in expression levels in many RIT mutants and were characterized in more detail. Analysis of the deduced amino acid sequence encoded by AfuMDR3 revealed high similarity to major facilitator superfamily transporters, while AfuMDR4 was a typical member of the ATP-binding cassette superfamily. Real-time quantitative PCR with molecular beacon probes was used to assess expression levels of AfuMDR3 and AfuMDR4 . Most RIT mutants showed either constitutive high-level expression of both genes or induction of expression upon exposure to itraconazole. Our results suggest that overexpression of one or both of these newly identified drug efflux pump genes of A. fumigatus and/or selection of drug target site mutations are linked to high-level itraconazole resistance and are mechanistic considerations for the emergence of clinical resistance to itraconazole.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Molecular Beacons: Probes that Fluoresce upon Hybridization
Tyagi, S., & Kramer, F. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-303 · Cited by 4,155
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Multicolor molecular beacons for allele discrimination
Tyagi, S., Bratu, D. P., & Kramer, F. R. (1998) · Nature Biotechnology · doi:10.1038/nbt0198-49 · Cited by 1,320
Quantitative RT-PCR: Pitfalls and Potential
Freeman, W. M., Walker, S. J., & Vrana, K. E. (1999) · BioTechniques · doi:10.2144/99261rv01 · Cited by 1,147
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“UV-induced mutations have the potential to promote different types of resistance mechanisms, including changes in the target lanosterol-14- -demethylase (30) and induction of highcapacity drug efflux pumps (1, 26, 29).”
BackgroundThermodynamic basis of the enhanced specificity of structured DNA probes
Bonnet, G., Tyagi, S., Libchaber, A., & Kramer, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6171 · Cited by 658
Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 531
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 508
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · cited 2×
“The ABC and the MFS comprise the two major classes of efflux pumps known to contribute to drug resistance (8, 27, 38).”
BackgroundSanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Intron—exon structures of eukaryotic model organisms
Long, M., & Deutsch, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.15.3219 · Cited by 417 · cited 1×
“A predicted intron of 61 nt presented a GT dinucleotide-splicing donation site sequence at the 5 end and an AG-splicing acceptor sequence site at the 3 end that are identical to those observed in genes of fungi and other organisms (6, 11).”
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis
Manganelli, R., Dubnau, E., Tyagi, S., Kramer, F. R., & Smith, I. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01212.x · Cited by 370
Fungal Transporters Involved in Efflux of Natural Toxic Compounds and Fungicides
Del Sorbo, G., Schoonbeek, H.-J., & De Waard, M. A. (2000) · Fungal Genetics and Biology · doi:10.1006/fgbi.2000.1206 · Cited by 357
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · cited 1×
“A reduced intracellular level of itraconazole has been identified as a cause of resistance in several posttreatment Candida sp. clinical isolates ( 31 ) and in some A. fumigatus isolates (20).”
BackgroundAntifungal drug resistance in pathogenic fungi.
BOSSCHE, H. V., Dromer, F., Improvisi, I., Lozano‐Chiu, M., Rex, J. H., & Sanglard, D. (1998) · PubMed · Cited by 290
Yeast multidrug resistance: The PDR network
Balzi, E., & Goffeau, A. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110333 · Cited by 279
Kolaczkowski, M., Kolaczkowska, A., Luczynski, J., Witek, S., & Goffeau, A. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.143 · Cited by 227
Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202 · cited 2×
“previously reported descriptions of AfuMDR1, AfuMDR2, and atrF (32, 35).”
BackgroundMann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 189
Self-citationDiethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood
Kitchen, L. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.241 · Cited by 183
Genetics and biochemistry of yeast multidrug resistance
Balzi, E., & Goffeau, A. (1994) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)90102-3 · Cited by 172
Lazéra, M. S., Cavalcanti, M. A. S., Trilles, L., Nishikawa, M. M., & Wanke, B. (1998) · Medical Mycology · doi:10.1080/02681219880000191 · Cited by 164
Geiser, D. M., Frisvad, J. C., & Taylor, J. W. (1998) · Mycologia · doi:10.1080/00275514.1998.12026977 · Cited by 145
Caspofungin: An echinocandin antifungal agent
Stone, E. A., Fung, H. B., & Kirschenbaum, H. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85039-1 · Cited by 143
Acquired itraconazole resistance in Aspergillus fumigatus
Dannaoui, E. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 143
Tobin, M. B., Peery, R. B., & Skatrud, P. L. (1997) · Gene · doi:10.1016/s0378-1119(97)00281-3 · Cited by 139
Azole Cross-Resistance in Aspergillus fumigatus
Mosquera, J., & Denning, D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.556-557.2002 · Cited by 121
Jaton-Ogay, K. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90506-j · Cited by 115
Verweij, P. E., Oakley, K. L., Morrissey, J., Morrissey, G., & Denning, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.873 · Cited by 104
Täpp, I., Malmberg, L., Rennel, E. S., Wik, M., & Syvänen, A.-C. (2000) · BioTechniques · doi:10.2144/00284rr02 · Cited by 101
Molecular genetics in Aspergillus fumigatus
Brookman, J. L., & Denning, D. W. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00124-7 · Cited by 96
Osherov, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.75 · Cited by 95
Manavathu, E. K., Vázquez, J. A., & Chandrasekar, P. H. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00102-2 · Cited by 65
Diagnosis and management of invasive aspergillosis.
Denning, D. W. (1996) · PubMed · Cited by 52
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis
Kurtz, M. B., Bernard, E. M., Edwards, F. F., Marrinan, J. A., Dropinski, J., Douglas, C. M., & Armstrong, D. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1784 · Cited by 49
Molecular Evaluation of the Plasma Membrane Proton Pump fromAspergillus fumigatus
Burghoorn, H. P., Soteropoulos, P., Paderu, P., Kashiwazaki, R., & Perlin, D. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.615-624.2002 · Cited by 34
Self-citationKuchler, K., Goransson, H. M., Viswanathan, M. N., & Thorner, J. W. (1992) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1992.057.01.064 · Cited by 24
Goffeau (1997) · doi:10.1002/(sici)1097-0061(199701)13:1
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R., et al. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.165-256.2006 · Cited by 1,318
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Self-citation
Metadata
- Authors
- Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-05
- Volume
- 47
- Issue
- 5
- Pages
- 1719-1726
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2100157937
- Cited by
- 258
- References
- 40
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.